107 related articles for article (PubMed ID: 18938028)
1. Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer.
Ko E; Kim Y; Lee BB; Han J; Song SY; Shim YM; Park J; Kim DH
Cancer Lett; 2009 Feb; 274(2):225-32. PubMed ID: 18938028
[TBL] [Abstract][Full Text] [Related]
2. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer.
Ko E; Kim Y; Park SE; Cho EY; Han J; Shim YM; Park J; Kim DH
Lung Cancer; 2012 Aug; 77(2):401-6. PubMed ID: 22534667
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
6. Expression of p16 and lack of pRB in primary small cell lung cancer.
Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K
J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
[TBL] [Abstract][Full Text] [Related]
9. RB growth control evasion in lung cancer.
Caputi M; Esposito V; Groger AM; De Luca A; Pacilio C; Dekan G; Giordano GG; Baldi F; Wolner E; Giordano A
Anticancer Res; 1998; 18(4A):2371-4. PubMed ID: 9703881
[TBL] [Abstract][Full Text] [Related]
10. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer.
Kim JS; Lee H; Kim H; Shim YM; Han J; Park J; Kim DH
J Clin Oncol; 2004 Sep; 22(17):3443-50. PubMed ID: 15277540
[TBL] [Abstract][Full Text] [Related]
12. Centrosome abnormalities in non-small cell lung cancer: correlations with DNA aneuploidy and expression of cell cycle regulatory proteins.
Jung CK; Jung JH; Lee KY; Kang CS; Kim M; Ko YH; Oh CS
Pathol Res Pract; 2007; 203(12):839-47. PubMed ID: 17913384
[TBL] [Abstract][Full Text] [Related]
13. Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study.
Malusecka E; Zborek A; Krzyzowska-Gruca S
Folia Histochem Cytobiol; 1999; 37(1):19-24. PubMed ID: 10091946
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers.
Tanaka H; Fujii Y; Hirabayashi H; Miyoshi S; Sakaguchi M; Yoon HE; Matsuda H
Int J Cancer; 1998 Apr; 79(2):111-5. PubMed ID: 9583722
[TBL] [Abstract][Full Text] [Related]
15. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.
Patel M; Lu L; Zander DS; Sreerama L; Coco D; Moreb JS
Lung Cancer; 2008 Mar; 59(3):340-9. PubMed ID: 17920722
[TBL] [Abstract][Full Text] [Related]
16. Differences between small-cell lung cancer and non-small-cell lung cancer among tobacco smokers.
Toh CK; Gao F; Lim WT; Leong SS; Fong KW; Yap SP; Hsu AA; Eng P; Koong HN; Thirugnanam A; Tan EH
Lung Cancer; 2007 May; 56(2):161-6. PubMed ID: 17270313
[TBL] [Abstract][Full Text] [Related]
17. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
18. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).
Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; JaĆkiewicz K; Czestochowska E
J Cancer Res Clin Oncol; 2005 Jul; 131(7):479-85. PubMed ID: 15809880
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
Kim DS; Kim MJ; Lee JY; Lee SM; Choi JY; Yoon GS; Na YK; Hong HS; Kim SG; Choi JE; Lee SY; Park JY
Mol Carcinog; 2009 Dec; 48(12):1109-15. PubMed ID: 19554572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]